Menu

Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry Case SWOT Analysis

Case Study Solution And Analysis


Home >> Darden >> Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry >> Swot Analysis

Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry Case Study Solution

The internal analysis and external of the company likewise can be done through SWOT Analysis, summarized in the Display F.

Strengths

• Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry has an experience of about 140 years, enabling business to much better carry out, in numerous circumstances.
• Nestlé's has existence in about 86 countries, making it an international leader in Food and Drink Market.
• Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry has more than 2000 brand names, which increase the circle of its target customers. These brands include infant foods, animal food, confectionary items, beverages etc. Famous brands of Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry include; Maggi, Kit-Kat, Nescafe, etc.
• Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry has large amount of costs on R&D as compare to its competitors, making the business to launch more ingenious and healthy items. This innovation offers the company a high competitive position in long term.
• After adopting its NHW Method, the business has actually done big amount of mergers and acquisitions which increase the sales development and enhance market position of Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry.
• Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry is a widely known brand with high customer's commitment and brand recall. This brand name commitment of consumers increases the possibilities of easy market adoption of various brand-new brand names of Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry.

Weaknesses

• Acquisitions of those service, like; Kraft frozen Pizza business can give a negative signal to Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry consumers about their compromise over their core proficiency of much healthier foods.
• The growth I sales as compare to the business's financial investment in NHW Method are rather various. It will take long to alter the perception of people ab out Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry as a business offering healthy and nutritious products.

Opportunities

• Introducing more health related items enables the company to capture the market in which consumers are quite conscious about health.
• Developing countries like India and China has biggest markets in the world. Hence broadening the market towards establishing nations can improve the Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry organisation by increasing sales volume.
• Continue acquisitions and joint ventures increases the marketplace share of the business.
• Increased relationships with schools, hotel chains, dining establishments and so on can also increase the number of Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry customers. For instance, teachers can suggest their trainees to acquire Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry items.

Threats

• Financial instability in nations, which are the possible markets for Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry, can create a number of concerns for Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry.
• Shifting of products from normal to much healthier, causes extra expenses and can result in decline company's revenue margins.
• As Jan Eriksson At Novartis Indonesia Turmoil In The Indonesian Pharmaceutical Industry has a complex supply chain, for that reason failure of any of the level of supply chain can lead the business to face specific issues.

Exhibit F: SWOT Analysis